FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, E. F.
Right arrow Articles by Hsu, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, E. F.
Right arrow Articles by Hsu, M. H.

The FASEB Journal, Vol 10, 1241-1248, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation

EF Johnson, CN Palmer, KJ Griffin and MH Hsu
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037, USA.

Cytochrome P450s of the 4A subfamily generally catalyze the omega- hydroxylation of fatty acids. The induction of P450 4A enzymes by peroxisome proliferators or fatty acids is mediated by peroxisome proliferator-activated receptors (PPARs), which are members of the nuclear receptor family that regulates the expression of genes that control fatty acid synthesis, storage, and catabolism. PPARs bind as heterodimers with another member of the nuclear receptor family, the retinoid X receptor (RXR), to peroxisome proliferator response elements (PPREs) in the P450 4A1 and 4A6 genes. PPREs comprise two overlapping motifs for nuclear receptor binding. One motif consists of an imperfect, direct repeat of two copies of the nuclear receptor core binding site, AGGTCA, separated by a single nucleotide (a DR1 motif) that is recognized by other dimeric nuclear receptor complexes such as HNF-4 or ARP-1. A consensus sequence flanking the DR1 motif together with the 5' core binding site of the DR1 motif constitutes a second, overlapping motif resembling recognition elements for monomeric nuclear receptors, such as Rev-ErbA and the melatonin receptors. PPARs bind to the latter motif. The tripartite nature of PPREs together with imperfections in the core sites of DR1 motif confers specificity for PPAR alpha/RXR alpha binding to PPREs relative to other nuclear receptors.


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol, June 1, 2007; 35(4): 474 - 494.
[Abstract] [PDF]

Home page
 J. Lipid Res.Home page
A. Gatica, M. C. Aguilera, D. Contador, G. Loyola, C. O. Pinto, L. Amigo, J. E. Tichauer, S. Zanlungo, and M. Bronfman
P450 CYP2C epoxygenase and CYP4A {omega}-hydroxylase mediate ciprofibrate-induced PPAR{alpha}-dependent peroxisomal proliferation
J. Lipid Res., April 1, 2007; 48(4): 924 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. K. Shelby and C. D. Klaassen
Induction of Rat UDP-Glucuronosyltransferases in Liver and Duodenum by Microsomal Enzyme Inducers That Activate Various Transcriptional Pathways
Drug Metab. Dispos., October 1, 2006; 34(10): 1772 - 1778.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J.-H. Kim, K. Yamaguchi, S.-H. Lee, P. K. Tithof, G. S. Sayler, J.-H. Yoon, and S. J. Baek
Evaluation of Polycyclic Aromatic Hydrocarbons in the Activation of Early Growth Response-1 and Peroxisome Proliferator Activated Receptors
Toxicol. Sci., May 1, 2005; 85(1): 585 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
H. Duan and M. A. Schuler
Differential Expression and Evolution of the Arabidopsis CYP86A Subfamily
Plant Physiology, March 1, 2005; 137(3): 1067 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Guan
Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2801 - 2815.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. L. Raucy, J. Lasker, K. Ozaki, and V. Zoleta
Regulation of CYP2E1 by Ethanol and Palmitic Acid and CYP4A11 by Clofibrate in Primary Cultures of Human Hepatocytes
Toxicol. Sci., June 1, 2004; 79(2): 233 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Jia, C. Qi, Z. Zhang, T. Hashimoto, M. S. Rao, S. Huyghe, Y. Suzuki, P. P. Van Veldhoven, M. Baes, and J. K. Reddy
Overexpression of Peroxisome Proliferator-activated Receptor-{alpha} (PPAR{alpha})-regulated Genes in Liver in the Absence of Peroxisome Proliferation in Mice Deficient in both L- and D-Forms of Enoyl-CoA Hydratase/Dehydrogenase Enzymes of Peroxisomal {beta}-Oxidation System
J. Biol. Chem., November 21, 2003; 278(47): 47232 - 47239.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
F. Yadetie, A. Laegreid, I. Bakke, W. Kusnierczyk, J. Komorowski, H. L. Waldum, and A. K. Sandvik
Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-{alpha} agonist ciprofibrate
Physiol Genomics, September 29, 2003; 15(1): 9 - 19.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Meyer, J.-S. Lee, P. A. Dyck, W.-Q. Cao, M.S. Rao, S. S. Thorgeirsson, and J. K. Reddy
Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen
Carcinogenesis, May 1, 2003; 24(5): 975 - 984.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Cowart, S. Wei, M.-H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila
The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands
J. Biol. Chem., September 13, 2002; 277(38): 35105 - 35112.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. Sinal, M. Yoon, and F. J. Gonzalez
Antagonism of the Actions of Peroxisome Proliferator-activated Receptor-alpha by Bile Acids
J. Biol. Chem., December 7, 2001; 276(50): 47154 - 47162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. K. Reddy
Nonalcoholic Steatosis and Steatohepatitis: III. Peroxisomal beta -oxidation, PPARalpha , and steatohepatitis
Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1333 - G1339.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Yu, W.-Q. Cao, P. Kashireddy, K. Meyer, Y. Jia, D. E. Hughes, Y. Tan, J. Feng, A. V. Yeldandi, M. S. Rao, et al.
Human Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Supports the Induction of Peroxisome Proliferation in PPARalpha -deficient Mouse Liver
J. Biol. Chem., November 2, 2001; 276(45): 42485 - 42491.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. R. Holla, F. Adas, J. D. Imig, X. Zhao, E. Price Jr., N. Olsen, W. J. Kovacs, M. A. Magnuson, D. S. Keeney, M. D. Breyer, et al.
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension
PNAS, April 24, 2001; 98(9): 5211 - 5216.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Yoshinari, T. Sueyoshi, R. Moore, and M. Negishi
Nuclear Receptor CAR as a Regulatory Factor for the Sexually Dimorphic Induction of CYP2B1 Gene by Phenobarbital in Rat Livers
Mol. Pharmacol., February 1, 2001; 59(2): 278 - 284.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
S. R. Mitchell, M. B. Sewer, S. S. Kardar, and E. T. Morgan
Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia
Drug Metab. Dispos., January 1, 2001; 29(1): 17 - 22.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. A. Baumann, N. Chokshi, A. R. Saltiel, and V. Ribon
Cloning and Characterization of a Functional Peroxisome Proliferator Activator Receptor-gamma -responsive Element in the Promoter of the CAP Gene
J. Biol. Chem., March 24, 2000; 275(13): 9131 - 9135.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. H. Capdevila, J. R. Falck, and R. C. Harris
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
J. Lipid Res., February 1, 2000; 41(2): 163 - 181.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev., October 1, 1999; 20(5): 689 - 725.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
S. Y. Moya-Camarena, J. P. V. Heuvel, S. G. Blanchard, L. A. Leesnitzer, and M. A. Belury
Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR{alpha}
J. Lipid Res., August 1, 1999; 40(8): 1426 - 1433.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. Hashimoto, T. Fujita, N. Usuda, W. Cook, C. Qi, J. M. Peters, F. J. Gonzalez, A. V. Yeldandi, M. S. Rao, and J. K. Reddy
Peroxisomal and Mitochondrial Fatty Acid beta -Oxidation in Mice Nullizygous for Both Peroxisome Proliferator-activated Receptor alpha  and Peroxisomal Fatty Acyl-CoA Oxidase. GENOTYPE CORRELATION WITH FATTY LIVER PHENOTYPE
J. Biol. Chem., July 2, 1999; 274(27): 19228 - 19236.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
V. GROSS, W. SCHNEIDER, W.-H. SCHUNCK, E. MERVAALA, and F. C. LUFT
Chronic Effects of Lovastatin and Bezafibrate on Cortical and Medullary Hemodynamics in Deoxycorticosterone Acetate-Salt Hypertensive Mice
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1430 - 1439.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
F. Guéraud, J. Alary, P. Costet, L. Debrauwer, L. Dolo, T. Pineau, and A. Paris
In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPAR{alpha}-deficient mice
J. Lipid Res., January 1, 1999; 40(1): 152 - 159.
[Abstract] [Full Text]

Home page
 Plant Physiol.Home page
F. Pinot, I. Benveniste, J.-P. Salaün, and F. Durst
Methyl Jasmonate Induces Lauric Acid omega -Hydroxylase Activity and Accumulation of CYP94A1 Transcripts but Does Not Affect Epoxide Hydrolase Activities in Vicia sativa Seedlings
Plant Physiology, December 1, 1998; 118(4): 1481 - 1486.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
M.-H. Hsu, C. N. A. Palmer, W. Song, K. J. Griffin, and E. F. Johnson
A Carboxyl-terminal Extension of the Zinc Finger Domain Contributes to the Specificity and Polarity of Peroxisome Proliferator-activated Receptor DNA Binding
J. Biol. Chem., October 23, 1998; 273(43): 27988 - 27997.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. Honkakoski, I. Zelko, T. Sueyoshi, and M. Negishi
The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene
Mol. Cell. Biol., October 1, 1998; 18(10): 5652 - 5658.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C.-Y. Fan, J. Pan, N. Usuda, A. V. Yeldandi, M. S. Rao, and J. K. Reddy
Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase. IMPLICATIONS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR alpha  NATURAL LIGAND METABOLISM
J. Biol. Chem., June 19, 1998; 273(25): 15639 - 15645.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Hellmold, T. Rylander, M. Magnusson, E. Reihnér, M. Warner, and J.-A. Gustafsson
Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction Mammaplasties
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 886 - 895.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
J. H. Lin and A. Y. H. Lu
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Pharmacol. Rev., December 1, 1997; 49(4): 403 - 449.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Galli, J. Pinaire, M. Fischer, R. Dorris, and D. W. Crabb
The Transcriptional and DNA Binding Activity of Peroxisome Proliferator-activated Receptor alpha Is Inhibited by Ethanol Metabolism. A NOVEL MECHANISM FOR THE DEVELOPMENT OF ETHANOL-INDUCED FATTY LIVER
J. Biol. Chem., January 5, 2001; 276(1): 68 - 75.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The Federation of American Societies for Experimental Biology.